CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 6 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $94,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Bay Capital Management LP | 2,000,000 | $6,802,000 | 0.16% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Invesco Ltd. | 24,716 | $88,000 | 0.00% |
| ROYAL BANK OF CANADA | 7 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 20,153 | $72,000 | 0.00% |
| UBS Group AG | 1,971 | $7,000 | 0.00% |